Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Natamycin [skin] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nystatin [skin] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Terbinafine hydrochloride [2] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Minor skin infection preparations |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzalkonium chloride 50% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Silver nitrate [disinfectant] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Medicinal product containing cyclic lipopeptide and acting as antibacterial agent (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing daptomycin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing benzocaine and triclosan (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Terbinafine hydrochloride 10 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluocinolone acetonide+clioquinol 0.025%/3% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluocinolone acetonide+clioquinol 0.025%/3% ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluocinolone acetonide 250 microgram/g and neomycin sulfate 5 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Terbinafine hydrochloride 10 mg/mL cutaneous spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Neomycin sulfate 25 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mafenide acetate 85mg/g cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mafenide acetate 5% solution (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sulconazole nitrate 10 mg/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ciclopirox olamine 1% gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ciclopirox olamine 1% lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ciclopirox olamine 8% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Haloprogin 1% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Haloprogin 10 mg/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxiconazole nitrate 1% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxiconazole nitrate 1% lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely nystatin 500000 unit/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nystatin 1 million unit oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nystatin 200000 unit oromucosal lozenge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clioquinol+hydrocortisone 3%/0.5% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Naftifine hydrochloride 1% gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely natamycin 50 milligram/1 milliliter conventional release eye suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Polymyxin B sulfate+bacitracin zinc 10,000u/500u ophthalmic ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hexachlorophene 30 mg/mL cutaneous emulsion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hexachlorophene 3% soap |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely chloroxine 20 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ciclopirox olamine 1% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mafenide acetate 112mg cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mafenide acetate 5% powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Naftifine hydrochloride 1.0% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely ciclopirox 80 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ciclopirox 0.77% gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ciclopirox 0.77% lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ciclopirox 0.77% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Povidone-iodine 10% |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Miconazole nitrate 200 mg vaginal pessary |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Miconazole nitrate 200mg/sup pessary |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzoyl peroxide 10% |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely benzoyl peroxide 100 microgram/1 milligram conventional release cutaneous gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzoyl peroxide 4% lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzoyl peroxide 3% gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzoyl peroxide 4% gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzoyl peroxide 8% gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzoyl peroxide 8% lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzoyl peroxide 8% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzoyl peroxide 10% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzoyl peroxide 5% (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzoyl peroxide 6% gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nystatin 100 unit/mg cutaneous powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triclosan 0.1% liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nystatin 100 unit/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Miconazole nitrate 2%wv cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Miconazole nitrate 200mg cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely terbinafine (as terbinafine hydrochloride) 10 milligram/1 gram conventional release cutaneous solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Silver sulfadiazine 10mg/g cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mupirocin calcium 2% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzoyl peroxide 7% (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Povidone-iodine 10% liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzoyl peroxide 3% |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Natamycin 5% suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tetracycline hydrochloride 1%wv suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tetracycline hydrochloride 1% ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Polymyxin b sulfate 100% powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bacitracin zinc + neomycin sulfate + polymyxin b sulfate 400unt/3.5gm/10000unt ointment (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bacitracin zinc + polymyxin b sulphate 500unt/10000unt ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzoyl peroxide + clindamycin phosphate 50mg/10mg gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzoyl peroxide + erythromycin 50mg/30mg gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzoyl peroxide + hydrocortisone 50mg/5mg lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzoyl peroxide + sulfur 10%ww/5%ww |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzoyl peroxide + sulfur 5%ww/2%ww |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clioquinol + hydrocortisone + pramoxine hydrochloride 3%ww/1%ww/0.5%ww |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clioquinol + hydrocortisone 3%ww/0.5%ww cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clioquinol + hydrocortisone 3%ww/0.5%ww lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clioquinol + hydrocortisone 30mg/10mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Colistin sulfate + hydrocortisone acetate + neomycin sulfate 0ns/10mg/0ns solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dexamethasone + neomycin sulfate + polymyxin b sulfate 0.1%wv/ns/10000unt ointment (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dexamethasone + neomycin sulfate + polymyxin b sulphate 0.1%wv/ns/10000unt suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dexamethasone + neomycin sulphate 1mg/3.5mg ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dexamethasone sodium phosphate + neomycin sulfate 1mg/3.5gm solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Gramicidin + neomycin sulfate + polymyxin b sulphate 0.025mg/1.75mg/10000unt solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hexachlorophene + hydrocortisone + menthol 5mg/5mg/1.25mg topical cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone + neomycin sulfate + polymyxin b sulphate 10mg/5mg/1.6mg suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/10000unt sol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone+neomycin sulfate+polymyxin b sulphate 10mg/5ns/10000unt suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone + neomycin sulfate + polymyxin b sulphate 10mg/7.5mg/10000unt suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone + neomycin sulfate + polymyxin b sulphate 10mg/7.5mg/1000unt solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone + polymyxin b 5mg/10000unt drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone acetate + neomycin sulfate + polymyxin b sulfate 5mg/3.5mg/10000unit cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nystatin + triamcinolone acetonide 100000unt/1mg cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nystatin + triamcinolone acetonide 100000unt/1mg ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|